Medicare Enrolled

Dr. Dana Pan, MD

Hepatology Physician · San Gabriel, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
207 S SANTA ANITA ST STE P15, San Gabriel, CA 91776
6268984560
In practice since 2014 (11 years)
NPI: 1265842934 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pan

Dr. Dana Pan is a hepatology physician in San Gabriel, CA, with 11 years of NPI registration. Based on federal Medicare data, Dr. Pan performed 1,121 Medicare services across 963 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pan received a total of $7,689 from 29 pharmaceutical and/or device companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hepatology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 11 years in practice ▲ Top 32% volume in CA $7,689 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,121
Medicare services
Top 32% in CA for hepatology physician
963
Unique beneficiaries
$101
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~102 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
224 $71 $438
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
163 $104 $601
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
109 $120 $780
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
97 $70 $540
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
93 $80 $677
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
78 $129 $898
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
59 $147 $776
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
43 $68 $355
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
42 $214 $1,078
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
38 $102 $534
Radiologist review of bile duct tube placement imaging
A radiologist reviews images taken during the placement of a tube into the bile duct using an endoscope.
27 $20 $117
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
25 $177 $796
Endoscopic removal of bile or pancreatic duct stone
A flexible endoscope is used to remove stones or debris from the bile or pancreatic ducts.
24 $107 $1,569
Complete ultrasound of abdomen
A diagnostic imaging test that uses sound waves to create detailed pictures of the organs and structures within the abdomen.
22 $66 $438
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
21 $79 $557
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $110 $455
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
15 $121 $801
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
13 $153 $840
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
11 $195 $719
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,689
Total received (2020-2024)
Avg $1,538/year across 5 years
Top 32% in CA for hepatology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
29
Companies
377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,689 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,912
2023
$2,164
2022
$1,563
2021
$1,436
2020
$614

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$453
Phathom Pharmaceuticals, Inc.
$374
Janssen Biotech, Inc.
$203
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$195
Ardelyx, Inc.
$175
Takeda Pharmaceuticals U.S.A., Inc.
$153
Celgene Corporation
$103
GENZYME CORPORATION
$59
QOL Medical, LLC
$54
IRONWOOD PHARMACEUTICALS, INC
$38
Madrigal Pharmaceuticals
$37
Gilead Sciences, Inc.
$23
Merck Sharp & Dohme LLC
$16
Ferring Pharmaceuticals Inc.
$14
PFIZER INC.
$13
Top 3 companies account for 53.9% of 2024 payments
All-time payments by company (2020-2024) ›
ABBVIE INC.
$1,458
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$722
AbbVie Inc.
$700
Janssen Biotech, Inc.
$604
Takeda Pharmaceuticals U.S.A., Inc.
$547
Celgene Corporation
$460
Ironwood Pharmaceuticals, Inc
$408
Phathom Pharmaceuticals, Inc.
$374
Ardelyx, Inc.
$343
Gilead Sciences, Inc.
$309
INTERCEPT PHARMACEUTICALS, INC.
$246
RedHill Biopharma Inc.
$237
E.R. Squibb & Sons, L.L.C.
$236
QOL Medical, LLC
$147
Merck Sharp & Dohme Corporation
$129
Novartis Pharmaceuticals Corporation
$126
Olympus America Inc.
$125
Regeneron Healthcare Solutions, Inc.
$101
IRONWOOD PHARMACEUTICALS, INC
$99
Merck Sharp & Dohme LLC
$82
GENZYME CORPORATION
$81
Madrigal Pharmaceuticals
$37
Nestle HealthCare Nutrition Inc.
$25
VIVUS LLC
$20
Evoke Pharma, Inc.
$20
Ferring Pharmaceuticals Inc.
$14
PFIZER INC.
$13
Intercept Pharmaceuticals, Inc.
$13
ERBE USA Inc
$13
Top 3 companies account for 37.4% of all-time payments
Associated products mentioned in payments ›
CREON · DIFICID · DUPIXENT · ENTYVIO · Erbe VIO3 · GIMOTI · HUMIRA · IBSRELA · LEQVIO · LINZESS · Linzess · MAVYRET · MOTEGRITY · OCALIVA · Olympus Duodenoscopes · PANCREAZE · REBYOTA · REMICADE · RESMETIROM · RINVOQ · SKYRIZI · STELARA · SUCRAID · TREMFYA · TRULANCE · Talicia · VIBERZI · VOQUEZNA · Vemlidy · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hepatology physician in San Gabriel?
Compare hepatology physicians in the San Gabriel area by procedure volume, costs, and industry payment transparency.
Browse hepatology physicians nearby

Geographic Context

Hepatology physicians within 10 mi
15
Per 100K population
0.2
County median income
$87,760
Nearest hospital
SAN GABRIEL VALLEY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pan is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pan experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Pan performed 224 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pan receive payments from pharmaceutical companies?
Yes. Dr. Pan received a total of $7,689 from 29 companies across 377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pan's costs compare to other hepatology physicians in San Gabriel?
Dr. Pan's average Medicare payment per service is $101. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →